A Phase I Study of GT300 in Healthy Subjects

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
Descriptive safety and pharmacokinetics of GT300, exploratory biomarker effects for the evaluation of the effect of GT300 on the autophagy-lysosomal pathway (ALP), food effect on PK and fasting effect on biomarkers.
Epistemonikos ID: 47d7bd37c1a8634a535ee2e3203686dd22c2237e
First added on: Oct 02, 2023